Discover
DGX
Quest Diagnostics Incorporated
216.02
300 x undefined
100 x undefined
bid
ask
+
4.07
1.92%
200 @ 05:26 AM
217.09 +1.07 (0.50%)
| Ytd | 24.49% | |
| 1y | 20.46% |
211.40
day range
216.87
164.65
52 week range
216.87
| Open | 213.67 | Prev Close | 211.95 | Low | 211.40 | High | 216.87 | Mkt Cap | 23.91B |
| Vol | 679.81K | Avg Vol | 914.20K | EPS | 9.05 | P/E | 23.87 | Forward P/E | 18.51 |
| Beta | 0.59 | Short Ratio | 4.17 | Inst. Own | 97.85% | Dividend | 3.44 | Div Yield | 1.62 |
| Ex Div Date | 07-08 | Earning | 07-23 | 50-d Avg | 196.86 | 200-d Avg | 190.56 | 1yr Est | 223.44 |
| Income Statement | |||
| Total Revenue | 2.90B | ||
| Revenues (USD) | 2.90B | ||
| Cost of Revenue | 1.95B | ||
| Gross Profit | 942.00M | ||
| Operating Expenses | 543.00M | ||
| Selling, General and Administrative Expense | 504.00M | ||
| Operating Income | 399.00M | ||
| Interest Expense | 63.00M | ||
| Income Tax Expense | 74.00M | ||
| Net Income | 252.00M | ||
| Net Income Common Stock | 252.00M | ||
| Net Income Common Stock (USD) | 252.00M | ||
| Consolidated Income | 264.00M | ||
| Net Income to Non-Controlling Interests | 12.00M | ||
| Earnings per Basic Share | 2.27 | ||
| Earnings per Basic Share (USD) | 2.27 | ||
| Earnings per Diluted Share | 2.24 | ||
| Dividends per Basic Common Share | 0.80 | ||
| Earning Before Interest & Taxes (EBIT) | 389.00M | ||
| Earning Before Interest & Taxes (USD) | 389.00M | ||
| Weighted Average Shares | 110.00M | ||
| Weighted Average Shares Diluted | 112.00M | ||
| Balance Sheet | |||
| Cash and Equivalents | 393.00M | ||
| Cash and Equivalents (USD) | 393.00M | ||
| Investments | 134.00M | ||
| Investments Non-Current | 134.00M | ||
| Trade and Non-Trade Receivables | 1.59B | ||
| Current Assets | 2.57B | ||
| Property, Plant & Equipment Net | 2.88B | ||
| Total Assets | 16.67B | ||
| Debt Current | 677.00M | ||
| Total Debt | 6.41B | ||
| Current Liabilities | 2.18B | ||
| Debt Non-Current | 5.73B | ||
| Total Liabilities | 9.01B | ||
| Accumulated Retained Earnings (Deficit) | 10.15B | ||
| Accumulated Other Comprehensive Income | -43.00M | ||
| Shareholders Equity | 7.37B | ||
| Shareholders Equity (USD) | 7.37B | ||
| Assets Non-Current | 14.11B | ||
| Total Debt (USD) | 6.41B | ||
| Goodwill and Intangible Assets | 10.84B | ||
| Inventory | 225.00M | ||
| Liabilities Non-Current | 6.83B | ||
| Trade and Non-Trade Payables | 1.50B | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 147.00M | ||
| Net Cash Flow from Financing | -152.00M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -27.00M | ||
| Capital Expenditure | -114.00M | ||
| Net Cash Flow - Business Acquisitions and Disposals | -38.00M | ||
| Issuance (Purchase) of Equity Shares | 65.00M | ||
| Issuance (Repayment) of Debt Securities | -1000.00K | ||
| Payment of Dividends & Other Cash Distributions | -88.00M | ||
| Net Cash Flow from Investing | -152.00M | ||
| Net Cash Flow from Operations | 278.00M | ||
| Effect of Exchange Rate Changes on Cash | -1000.00K | ||
| Share Based Compensation | 20.00M | ||